IU School of Medicine now belongs to a global network of 48 leading medical centers around the world, 35 of those within the United States. Together, these centers provide expert care to more than 145,000 people with Parkinson disease.
Parkinson’s disease research at IU School of Medicine spans multiple areas. Clinical trials of new Parkinson’s medicines include drugs to treat the symptoms of Parkinson’s disease as well as drugs to slow the course of the disease. Researchers are investigating the impact of Deep Brain Stimulation and focused ultrasound as treatments for Parkinson’s disease motor symptoms. Researchers are using sensors to examine arm movements in Parkinson's disease and to measure gait changes. Genetic research in Parkinson’s disease is important as new drugs are being developed which may target people who carry a specific Parkinson’s gene. Environmental toxins likely contribute to disease risk; studies are investigating the role of manganese in welders and chlorpyrifos in veterans. Living well with Parkinson’s disease is a goal of treatment. Researchers are investigating the impacts of Rock Steady Boxing, and the role of art therapy in Parkinson’s disease.